Villarreal-Garza Cynthia, Martinez-Cannon Bertha Alejandra, Barragan-Carrillo Regina, Bargallo-Rocha Juan Enrique, Platas Alejandra, Peña-Curiel Omar, Torres Juan, Castro-Sanchez Andrea, Mohar Alejandro, Rivera Samuel
Department of Research and Breast Tumors, Instituto Nacional de Cancerología (INCan), Mexico City; Breast Cancer Center, Hospital Zambrano Hellion, Tecnológico de Monterrey, San Pedro Garza García, Monterrey; Joven y Fuerte: Program for the Care and Research of Young Women with Breast Cancer in Mexico, Mexico City; Mexico.
Breast Cancer Center, Hospital Zambrano Hellion, Tecnológico de Monterrey, San Pedro Garza García, Monterrey; Joven y Fuerte: Program for the Care and Research of Young Women with Breast Cancer in Mexico, Mexico City, Mexico.
Rev Invest Clin. 2021 Nov 5;73(6):347-353. doi: 10.24875/RIC.20000064.
In Mexico, up to 15% of breast cancer (BC) patients are 40 years or younger. Therefore, fertility preservation and pregnancy after cancer treatment are major concerns in this population. However, no data are available regarding Mexican physicians' knowledge and attitudes toward these issues.
The objective of the study was to describe physicians' attitudes, knowledge, and perceived barriers toward fertility preservation among young women with BC (YWBC) in a developing country.
A cross-sectional study was conducted among physicians attending the 2016 Mexican Society of Oncology (SMeO) Annual Meeting or affiliated to SMeO. Chi-squared tests were used to assess factors associated with a higher likelihood of disclosing infertility risks, discussing fertility preservation methods, referring to specialists, and effective counseling.
Of the 314 participants, 83% reported a high sense of responsibility about informing treatment-related infertility risks, 58% always informed patients about those risks, 38% always discussed fertility preservation procedures, 52% always referred interested patients to fertility specialists, and 24% wrongly considered pregnancy and GnRH analogs detrimental in YWBC. Barriers for discussing fertility preservation were costs, lack of specialists, and prognosis.
It is crucial to promote physicians' knowledge and to endorse policies to overcome barriers obstructing universal access to fertility preservation for YWBC in Mexico.
在墨西哥,高达15%的乳腺癌患者年龄在40岁及以下。因此,癌症治疗后的生育力保存和妊娠是这一人群的主要关注点。然而,关于墨西哥医生对这些问题的了解和态度,尚无相关数据。
本研究的目的是描述发展中国家年轻乳腺癌女性(YWBC)的医生对生育力保存的态度、知识和感知到的障碍。
对参加2016年墨西哥肿瘤学会(SMeO)年会或隶属于SMeO的医生进行了一项横断面研究。采用卡方检验评估与更高可能性披露不孕风险、讨论生育力保存方法、转诊至专科医生以及有效咨询相关的因素。
在314名参与者中,83%报告在告知与治疗相关的不孕风险方面有高度责任感,58%总是告知患者这些风险,38%总是讨论生育力保存程序,52%总是将感兴趣的患者转诊至生育专家,24%错误地认为妊娠和促性腺激素释放激素类似物对YWBC有害。讨论生育力保存的障碍包括费用、缺乏专家和预后。
促进医生的知识并支持相关政策以克服阻碍墨西哥YWBC普遍获得生育力保存的障碍至关重要。